ERIS Lifesciences consolidated net profit rises 17.66% in the March 2022 quarter

3 May 2022 , 03:49 PM

Net profit of ERIS Lifesciences rose 17.66% to Rs 80.30 crore in the quarter ended March 2022 as against Rs 68.25 crore during the previous quarter ended March 2021. Sales rose 9.79% to Rs 301.10 crore in the quarter ended March 2022 as against Rs 274.25 crore during the previous quarter ended March 2021.

For the full year,net profit rose 14.35% to Rs 406.11 crore in the year ended March 2022 as against Rs 355.14 crore during the previous year ended March 2021. Sales rose 11.20% to Rs 1326.17 crore in the year ended March 2022 as against Rs 1192.64 crore during the previous year ended March 2021.

Particulars	Quarter Ended	Year Ended
?	Mar. 2022	Mar. 2021	% Var.	Mar. 2022	Mar. 2021	% Var.
Sales	301.10	274.25	10	1326.17	1192.64	11
OPM %	32.18	34.46	–	36.57	36.10	–
PBDT	103.70	96.19	8	506.90	437.48	16
PBT	85.34	84.73	1	442.20	394.50	12
NP	80.30	68.25	18	406.11	355.14	14

Powered by Capital Market – Live News